新型冠狀病毒感染相關ARDS行體外膜氧合的生存預測研究進展_Chinese Journal of Respiratory and Critical Care Medicine

Authors：

黃維超 , 師姍姍 ,  郭文欽

中國醫學科學院阜外醫院深圳醫院重癥醫學科（廣東深圳 518000）;

Corresponding?author：

郭文欽, Email: guowenqin2011@outlook.com

Keywords：

DOI：

10.7507/1671-6205.202312008

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 黃維超, 師姍姍, 郭文欽. 新型冠狀病毒感染相關ARDS行體外膜氧合的生存預測研究進展. Chinese Journal of Respiratory and Critical Care Medicine, 2024, 23(7): 524-528. doi: 10.7507/1671-6205.202312008 Copy

1.	Noah MA, Peek GJ, Finney SJ, et al. Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A(H1N1). JAMA, 2011, 306(15): 1659-1668.
2.	Alshahrani MS, Sindi A, Alshamsi F, et al. Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus. Ann Intensive Care, 2018, 8(1): 3.
3.	Supady A, Badulak J, Evans L, et al. Should we ration extracorporeal membrane oxygenation during the COVID-19 pandemic?. Lancet Respir Med, 2021, 9(4): 326-328.
4.	Hajage D, Combes A, Guervilly C, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: an emulated target trial analysis. Am J Respir Crit Care Med, 2022, 206(3): 281-294.
5.	Urner M, Barnett AG, Bassi GL, et al. Venovenous extracorporeal membrane oxygenation in patients with acute covid-19 associated respiratory failure: comparative effectiveness study. BMJ, 2022, 377: e068723.
6.	中華醫學會呼吸病學分會危重癥學組. 奧密克戎變異株所致重癥新型冠狀病毒感染臨床救治專家推薦意見. 中華結核和呼吸雜志, 2022, 46(2): 101-110.
7.	Burn E, Sena A G, Uribe A P, et al. Use of dialysis, tracheostomy, and extracorporeal membrane oxygenation among 842, 928 patients hospitalized with COVID-19 in the United States. medRxiv [Preprint], 2021: 2020.11. 25.20229088.
8.	Karagiannidis C, Slutsky AS, Bein T, et al. Complete countrywide mortality in COVID patients receiving ECMO in Germany throughout the first three waves of the pandemic. Crit Care, 2021, 25(1): 413.
9.	劉春濤. 新冠病毒感染診療方案第十版發布, 診治方案之爭塵埃落地了嗎?. 中國呼吸與危重監護雜志, 2023, 22(1): 1-6.
10.	Pladet LCA, Barten JMM, Vernooij LM, et al. Prognostic models for mortality risk in patients requiring ECMO. Intensive Care Med, 2023, 49(2): 131-141.
11.	MacLaren G, Fisher D, Brodie D. Treating the most critically ill patients with COVID-19: the evolving role of extracorporeal membrane oxygenation. JAMA, 2022, 327(1): 31-32.
12.	Schmidt M, Zogheib E, Roze H, et al. The PRESERVE mortality risk score and analysis of long-term outcomes after extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. Intensive Care Med, 2013, 39(10): 1704-1713.
13.	Schmidt M, Bailey M, Sheldrake J, et al. Predicting survival after extracorporeal membrane oxygenation for severe acute respiratory failure. The Respiratory Extracorporeal Membrane Oxygenation Survival Prediction (RESP) score. Am J Respir Crit Care Med, 2014, 189(11): 1374-1382.
14.	Hilder M, Herbstreit F, Adamzik M, et al. Comparison of mortality prediction models in acute respiratory distress syndrome undergoing extracorporeal membrane oxygenation and development of a novel prediction score: the PREdiction of Survival on ECMO Therapy-Score (PRESET-Score). Crit Care, 2017, 21(1): 301.
15.	Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med, 1996, 22(7): 707-710.
16.	Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA, 1993, 270(24): 2957-2963.
17.	Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med, 1985, 13(10): 818-829.
18.	Enger T, Philipp A, Videm V, et al. Prediction of mortality in adult patients with severe acute lung failure receiving veno-venous extracorporeal membrane oxygenation: a prospective observational study. Crit Care, 2014, 18(2): R67.
19.	Raschke RA, Agarwal S, Rangan P, et al. Discriminant accuracy of the SOFA score for determining the probable mortality of patients with COVID-19 pneumonia requiring mechanical ventilation. JAMA, 2021, 325(14): 1469-1470.
20.	Badulak J, Antonini MV, Stead CM, et al. Extracorporeal Membrane Oxygenation for COVID-19: Updated 2021 Guidelines from the Extracorporeal Life Support Organization. ASAIO J, 2021, 67(5): 485-495.
21.	靳英輝, 詹慶元, 彭志勇, 等. 新型冠狀病毒肺炎藥物預防、診斷、治療與出院管理循證臨床實踐指南(更新版). 解放軍醫學雜志, 2020, 45(10): 1-20.
22.	Supady A, DellaVolpe J, Taccone FS, et al. Outcome prediction in patients with severe COVID-19 requiring extracorporeal membrane oxygenation-a retrospective international multicenter study. Membranes (Basel), 2021, 11(3): 170.
23.	Joshi H, Flanagan M, Subramanian R, et al. Respiratory ECMO survival prediction (RESP) score for COVID-19 patients treated with ECMO. ASAIO J, 2022, 68(4): 4864-91.
24.	Tabatabai A, Ghneim MH, Kaczorowski DJ, et al. Mortality risk assessment in COVID-19 venovenous extracorporeal membrane oxygenation. Ann Thorac Surg, 2021, 112(6): 1983-1989.
25.	Powell EK, Lankford AS, Ghneim M, et al. Decreased PRESET-Score corresponds with improved survival in COVID-19 veno-venous extracorporeal membrane oxygenation. Perfusion, 2022: 2676591221128237.
26.	Huespe IA, Lockhart C, Kashyap R, et al. Evaluation of the discrimination and calibration of predictive scores of mortality in ECMO for patients with COVID-19. Artif Organs, 2023, 47(6): 1007-1017.
27.	Moyon Q, Pineton de Chambrun M, Lebreton G, et al. Validation of survival prediction models for ECMO in Sars-CoV-2-related acute respiratory distress syndrome. Crit Care, 2022, 26(1): 187.
28.	Chan MC, Tseng JS, Chiu JT, et al. Prognostic value of plateau pressure below 30 cm H2O in septic subjects with acute respiratory failure. Respir Care, 2015, 60(1): 12-20.
29.	Gannon WD, Stokes JW, Gong W, et al. Predicting mortality for patients eligible for extracorporeal membrane oxygenation for COVID-19. Am J Respir Crit Care Med, 2022, 206(5): 628-632.
30.	Kieninger B, Kilger M, Foltan M, et al. Prognostic factors for favorable outcomes after veno-venous extracorporeal membrane oxygenation in critical care patients with COVID-19. PLoS One, 2023, 18(1): e0280502.
31.	COVID-19 National Preparedness Collaborators. Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021. Lancet, 2022, 399(10334): 1489-1512.
32.	Carabelli AM, Peacock TP, Thorne LG, et al. SARS-CoV-2 variant biology: immune escape, transmission and fitness. Nat Rev Microbiol, 2023, 21(3): 162-177.
33.	Pampati S, Rasberry CN, Timpe Z, et al. Disparities in implementing COVID-19 prevention strategies in public schools, United States, 2021-22 School Year. Emerg Infect Dis, 2023, 29(5): 937-944.
34.	Barbaro RP, MacLaren G, Boonstra PS, et al. Extracorporeal membrane oxygenation for COVID-19: evolving outcomes from the international Extracorporeal Life Support Organization Registry. Lancet, 2021, 398(10307): 1230-1238.
35.	Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med, 2020, 383(2): 120-128.
36.	Dorgham K, Quentric P, Gokkaya M, et al. Distinct cytokine profiles associated with COVID-19 severity and mortality. J Allergy Clin Immunol, 2021, 147(6): 2098-2107.
37.	Jimenez D, Garcia-Sanchez A, Rali P, et al. Incidence of VTE and bleeding among hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis. Chest, 2021, 159(3): 1182-1196.
38.	Paranjpe I, Fuster V, Lala A et al. Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19. J Am Coll Cardiol, 2020, 76(1): 122-124.
39.	傅小云, 周厚榮, 葉賢偉, 等. 淺析新型冠狀病毒肺炎并發急性呼吸窘迫綜合征的病理及病理生理. 中國呼吸與危重監護雜志, 2022, 21(10): 756-760.
40.	Tran A, Fernando SM, Rochwerg B, et al. Prognostic factors associated with mortality among patients receiving venovenous extracorporeal membrane oxygenation for COVID-19: a systematic review and meta-analysis. Lancet Respir Med, 2023, 11(3): 235-244.
41.	Emmarco AK, Toy BK, Pavone JM, et al. Experience of nurses caring for COVID-19 patients supported by venovenous extracorporeal membrane oxygenation (ECMO) after ECMO educational crash course. ASAIO J, 2023, 69(3): 267-271.

1. Noah MA, Peek GJ, Finney SJ, et al. Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A(H1N1). JAMA, 2011, 306(15): 1659-1668.
2. Alshahrani MS, Sindi A, Alshamsi F, et al. Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus. Ann Intensive Care, 2018, 8(1): 3.
3. Supady A, Badulak J, Evans L, et al. Should we ration extracorporeal membrane oxygenation during the COVID-19 pandemic?. Lancet Respir Med, 2021, 9(4): 326-328.
4. Hajage D, Combes A, Guervilly C, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: an emulated target trial analysis. Am J Respir Crit Care Med, 2022, 206(3): 281-294.
5. Urner M, Barnett AG, Bassi GL, et al. Venovenous extracorporeal membrane oxygenation in patients with acute covid-19 associated respiratory failure: comparative effectiveness study. BMJ, 2022, 377: e068723.
6. 中華醫學會呼吸病學分會危重癥學組. 奧密克戎變異株所致重癥新型冠狀病毒感染臨床救治專家推薦意見. 中華結核和呼吸雜志, 2022, 46(2): 101-110.
7. Burn E, Sena A G, Uribe A P, et al. Use of dialysis, tracheostomy, and extracorporeal membrane oxygenation among 842, 928 patients hospitalized with COVID-19 in the United States. medRxiv [Preprint], 2021: 2020.11. 25.20229088.
8. Karagiannidis C, Slutsky AS, Bein T, et al. Complete countrywide mortality in COVID patients receiving ECMO in Germany throughout the first three waves of the pandemic. Crit Care, 2021, 25(1): 413.
9. 劉春濤. 新冠病毒感染診療方案第十版發布, 診治方案之爭塵埃落地了嗎?. 中國呼吸與危重監護雜志, 2023, 22(1): 1-6.
10. Pladet LCA, Barten JMM, Vernooij LM, et al. Prognostic models for mortality risk in patients requiring ECMO. Intensive Care Med, 2023, 49(2): 131-141.
11. MacLaren G, Fisher D, Brodie D. Treating the most critically ill patients with COVID-19: the evolving role of extracorporeal membrane oxygenation. JAMA, 2022, 327(1): 31-32.
12. Schmidt M, Zogheib E, Roze H, et al. The PRESERVE mortality risk score and analysis of long-term outcomes after extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. Intensive Care Med, 2013, 39(10): 1704-1713.
13. Schmidt M, Bailey M, Sheldrake J, et al. Predicting survival after extracorporeal membrane oxygenation for severe acute respiratory failure. The Respiratory Extracorporeal Membrane Oxygenation Survival Prediction (RESP) score. Am J Respir Crit Care Med, 2014, 189(11): 1374-1382.
14. Hilder M, Herbstreit F, Adamzik M, et al. Comparison of mortality prediction models in acute respiratory distress syndrome undergoing extracorporeal membrane oxygenation and development of a novel prediction score: the PREdiction of Survival on ECMO Therapy-Score (PRESET-Score). Crit Care, 2017, 21(1): 301.
15. Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med, 1996, 22(7): 707-710.
16. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA, 1993, 270(24): 2957-2963.
17. Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med, 1985, 13(10): 818-829.
18. Enger T, Philipp A, Videm V, et al. Prediction of mortality in adult patients with severe acute lung failure receiving veno-venous extracorporeal membrane oxygenation: a prospective observational study. Crit Care, 2014, 18(2): R67.
19. Raschke RA, Agarwal S, Rangan P, et al. Discriminant accuracy of the SOFA score for determining the probable mortality of patients with COVID-19 pneumonia requiring mechanical ventilation. JAMA, 2021, 325(14): 1469-1470.
20. Badulak J, Antonini MV, Stead CM, et al. Extracorporeal Membrane Oxygenation for COVID-19: Updated 2021 Guidelines from the Extracorporeal Life Support Organization. ASAIO J, 2021, 67(5): 485-495.
21. 靳英輝, 詹慶元, 彭志勇, 等. 新型冠狀病毒肺炎藥物預防、診斷、治療與出院管理循證臨床實踐指南(更新版). 解放軍醫學雜志, 2020, 45(10): 1-20.
22. Supady A, DellaVolpe J, Taccone FS, et al. Outcome prediction in patients with severe COVID-19 requiring extracorporeal membrane oxygenation-a retrospective international multicenter study. Membranes (Basel), 2021, 11(3): 170.
23. Joshi H, Flanagan M, Subramanian R, et al. Respiratory ECMO survival prediction (RESP) score for COVID-19 patients treated with ECMO. ASAIO J, 2022, 68(4): 4864-91.
24. Tabatabai A, Ghneim MH, Kaczorowski DJ, et al. Mortality risk assessment in COVID-19 venovenous extracorporeal membrane oxygenation. Ann Thorac Surg, 2021, 112(6): 1983-1989.
25. Powell EK, Lankford AS, Ghneim M, et al. Decreased PRESET-Score corresponds with improved survival in COVID-19 veno-venous extracorporeal membrane oxygenation. Perfusion, 2022: 2676591221128237.
26. Huespe IA, Lockhart C, Kashyap R, et al. Evaluation of the discrimination and calibration of predictive scores of mortality in ECMO for patients with COVID-19. Artif Organs, 2023, 47(6): 1007-1017.
27. Moyon Q, Pineton de Chambrun M, Lebreton G, et al. Validation of survival prediction models for ECMO in Sars-CoV-2-related acute respiratory distress syndrome. Crit Care, 2022, 26(1): 187.
28. Chan MC, Tseng JS, Chiu JT, et al. Prognostic value of plateau pressure below 30 cm H2O in septic subjects with acute respiratory failure. Respir Care, 2015, 60(1): 12-20.
29. Gannon WD, Stokes JW, Gong W, et al. Predicting mortality for patients eligible for extracorporeal membrane oxygenation for COVID-19. Am J Respir Crit Care Med, 2022, 206(5): 628-632.
30. Kieninger B, Kilger M, Foltan M, et al. Prognostic factors for favorable outcomes after veno-venous extracorporeal membrane oxygenation in critical care patients with COVID-19. PLoS One, 2023, 18(1): e0280502.
31. COVID-19 National Preparedness Collaborators. Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021. Lancet, 2022, 399(10334): 1489-1512.
32. Carabelli AM, Peacock TP, Thorne LG, et al. SARS-CoV-2 variant biology: immune escape, transmission and fitness. Nat Rev Microbiol, 2023, 21(3): 162-177.
33. Pampati S, Rasberry CN, Timpe Z, et al. Disparities in implementing COVID-19 prevention strategies in public schools, United States, 2021-22 School Year. Emerg Infect Dis, 2023, 29(5): 937-944.
34. Barbaro RP, MacLaren G, Boonstra PS, et al. Extracorporeal membrane oxygenation for COVID-19: evolving outcomes from the international Extracorporeal Life Support Organization Registry. Lancet, 2021, 398(10307): 1230-1238.
35. Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med, 2020, 383(2): 120-128.
36. Dorgham K, Quentric P, Gokkaya M, et al. Distinct cytokine profiles associated with COVID-19 severity and mortality. J Allergy Clin Immunol, 2021, 147(6): 2098-2107.
37. Jimenez D, Garcia-Sanchez A, Rali P, et al. Incidence of VTE and bleeding among hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis. Chest, 2021, 159(3): 1182-1196.
38. Paranjpe I, Fuster V, Lala A et al. Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19. J Am Coll Cardiol, 2020, 76(1): 122-124.
39. 傅小云, 周厚榮, 葉賢偉, 等. 淺析新型冠狀病毒肺炎并發急性呼吸窘迫綜合征的病理及病理生理. 中國呼吸與危重監護雜志, 2022, 21(10): 756-760.
40. Tran A, Fernando SM, Rochwerg B, et al. Prognostic factors associated with mortality among patients receiving venovenous extracorporeal membrane oxygenation for COVID-19: a systematic review and meta-analysis. Lancet Respir Med, 2023, 11(3): 235-244.
41. Emmarco AK, Toy BK, Pavone JM, et al. Experience of nurses caring for COVID-19 patients supported by venovenous extracorporeal membrane oxygenation (ECMO) after ECMO educational crash course. ASAIO J, 2023, 69(3): 267-271.

Previous Article
慢性阻塞性肺疾病前期的早期識別、預測與干預措施的研究進展
Next Article
人工智能在結締組織相關間質性肺疾病的應用及研究進展

Chinese Journal of Respiratory and Critical Care Medicine

新型冠狀病毒感染相關ARDS行體外膜氧合的生存預測研究進展

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content